SCHEMBL24309350

SCHEMBL24309350

Cc1cccc(C)c1-c1cc(Oc2ccc(N3CCNCC3)c(Cl)c2)nc(NSc2cnn(C)c2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 5/20 0.33
▸ HTR1A P08908 4/20 0.33
▸ HTR3E A5X5Y0 1/20 0.32
▸ HTR3B O95264 1/20 0.32
▸ HTR3D Q70Z44 1/20 0.32
▸ HTR3C Q8WXA8 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ HTR7 P34969 3/20 0.32
▸ HTR2B P41595 3/20 0.32
▸ HTR2A P28223 2/20 0.32
▸ HTR2C P28335 2/20 0.32
▸ HTR6 P50406 2/20 0.32
▸ NMT1 P30419 1/20 0.32
▸ WEE1 P30291 2/20 0.31
▸ HTR5A P47898 1/20 0.31
▸ CDK4 P11802 1/20 0.31
▸ CCND1 P24385 1/20 0.31
▸ CCND2 P30279 1/20 0.31
▸ CCND3 P30281 1/20 0.31
▸ ADRB1 P08588 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310395 0.94 HTR3A (0.39) HTR3AHTR1AHTR3EHTR3BHTR3D
SCHEMBL24310587 0.89 FLT3 (0.37) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24309954 0.88 HTR1D (0.36) HTR1AHTR7HTR2AHTR6
SCHEMBL29567043 0.84 HTR6 (0.37) HTR1AHTR7HTR2BHTR2AHTR2C
SCHEMBL26837336 0.84 HTR6 (0.37) HTR1AHTR7HTR2BHTR2AHTR2C
SCHEMBL24310550 0.83 LMNA (0.33) —
SCHEMBL24309516 0.82 FLT3 (0.35) HTR3AHTR1AHTR3EHTR3BHTR3D
SCHEMBL24310533 0.82 MAP4K1 (0.35) —
SCHEMBL24310555 0.82 BTK (0.35) PIM1PIM3PIM2
SCHEMBL24310347 0.81 GPR39 (0.39) WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback